drugset / Trial / NCT00638755

The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic Rhinitis

NCT00638755 ↗

Phase 2 Completed 20 enrolled Capnia, Inc.
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of nasal CO2 on nasal congestion and other symptoms related to Perennial Allergic Rhinitis.

Timeline

Start
2008-02
Primary completion
2008-05
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Nasal Carbon Dioxide Unknown — Intranasal